We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Better response with conjugate vaccine than with polysaccaride vaccine 12 months after rituximab treatment in lymphoma patients.
- Authors
Svensson, Magnus; Dahlin, Ulrika; Kimby, Eva
- Abstract
The article focuses on a study which found that conjugate vaccine produced better response in lymphoma patients than polysaccharide vaccine after 12 months of rituximab treatment. It informs that rituximab depletes malignant CD20 expressing B cells but also normal CD20+ cells. The study supported indication of immunogenic conjugate vaccines and vaccinations before rituximab or immunochemotherapy in B-cell lymphoma patients.
- Subjects
B cell lymphoma; LYMPHOMAS; VACCINATION; ANTIGEN presenting cells; RITUXIMAB
- Publication
British Journal of Haematology, 2012, Vol 156, Issue 3, p407
- ISSN
0007-1048
- Publication type
Article
- DOI
10.1111/j.1365-2141.2011.08867.x